Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Beginning Cash Balance: 2009-2025

Historic Beginning Cash Balance for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $139.5 million.

  • Prestige Consumer Healthcare's Beginning Cash Balance rose 307.23% to $139.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.5 million, marking a year-over-year decrease of 14.20%. This contributed to the annual value of $46.5 million for FY2025, which is 20.55% down from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Beginning Cash Balance stood at $139.5 million for Q3 2025, which was up 42.52% from $97.9 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's 5-year Beginning Cash Balance high stood at $163.6 million for Q3 2021, and its period low was $21.0 million during Q1 2022.
  • Its 3-year average for Beginning Cash Balance is $67.6 million, with a median of $58.5 million in 2023.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Beginning Cash Balance tumbled by 78.08% in 2022 and then spiked by 310.88% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Beginning Cash Balance (Quarterly) stood at $42.8 million in 2021, then decreased by 0.88% to $42.4 million in 2022, then skyrocketed by 41.53% to $60.1 million in 2023, then decreased by 14.20% to $51.5 million in 2024, then soared by 307.23% to $139.5 million in 2025.
  • Its last three reported values are $139.5 million in Q3 2025, $97.9 million for Q2 2025, and $50.9 million during Q1 2025.